Skip to main content

Table 2 Biological functions and roles in breast cancer of proteins differentially expressed in CD133 low and CD133 high cells

From: In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133high to CD133low phenotype and reduces the CD133-related invasiveness

Proteins

Main function/Biological process

Known roles in breast cancer

CD133highversus CD133low

Tm4

Actin-binding protein/Cell motility

Metastasis (32), Chemotherapy resistance (34)

Up

14-3-3 ϵ

Protein binding/Cell cycle

Chemotherapy resistance (34)

Down

14-3-3 σ

Protein binding/Cell cycle, apoptosis

Tumor suppression (35)

Down

14-3-3 β/α

Protein binding/Cell cycle, apoptosis

Chemotherapy resistance (34)

Down

TCP-1-α

Molecular chaperone/Cell motility

Metastasis (36)

Down

LEI

Protease inhibitor/Protein metabolism

Cell migration and invasiveness suppression (37)

Down

AdoHcyase

Hydrolase/Protein metabolism

Oncogenic (38)

Up

eIF-2A

Initiation factor/Protein metabolism

Protein biosynthesis (39)

Down

PP2A- β

Protein phosphatase/Apoptosis

Tumor suppression (40)

Down

eIF3β

Initiation factor/Protein metabolism

Oncogenic (41)

Up

DDAH-1

Hydrolase/Metabolic pathways

Unknown

Down

PPase

Pyrophosphate hydrolysis/Metabolic pathways

Chemotherapy resistance (34)

Down

Annexin A3

Phospholipase A2 inhibitor/Metabolic pathways

Chemotherapy resistance (34)

Down

CapZ β

Actin capping/Cell motility

Chemotherapy resistance (34)

Down

PA28γ

Protein binding/Cell cycle, apoptosis

Unknown

Down